Canada Pension Plan Investment Board’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$183K Hold
41,300
– – ﹤0.01% 1613
2026
Q1
$180K Buy
+41,300
New +$195K ﹤0.01% 1587
2025
Q1
– Sell
-14,300
Closed -$92.8K – 1346
2024
Q4
$92.8K Buy
14,300
+11,900
+496% +$70.9K ﹤0.01% 1262
2024
Q3
$13.3K Buy
+2,400
New +$13.6K ﹤0.01% 1300

Other funds holding CTKB

Canada Pension Plan Investment Board's CTKB Position: Q2 2026 in Review

Canada Pension Plan Investment Board held its Cytek Biosciences (CTKB) position steady in Q2 2026 at 41,300 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

Canada Pension Plan Investment Board first reported a position in CTKB in Q3 2024 and has held it in 4 quarters since. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Canada Pension Plan Investment Board held 41,300 shares of Cytek Biosciences worth $183K as of Q2 2026.
  • Canada Pension Plan Investment Board left its Cytek Biosciences share count unchanged in Q2 2026.
  • Cytek Biosciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1613 holding.
  • Canada Pension Plan Investment Board first reported a position in Cytek Biosciences in Q3 2024 and has held it in 4 quarters since.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.